{
  "pmcid": "PMC4916189",
  "pmid": "26715213",
  "title": "Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Nai\u0308ve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study",
  "overall_score": 0.3047649766270603,
  "num_benchmarks": 4,
  "benchmarks": {
    "drug_annotations": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 0,
        "matched_count": 0,
        "unmatched_count": 0,
        "items": []
      },
      "extra_predictions": {
        "count": 10,
        "items": [
          {
            "variant": "CYP2B6",
            "gene": "CYP2B6",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "CYP2B6",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Lower risk of CNS-related adverse events was associated with CYP2B6 983TC/CC (OR 0.35, 95 % CI 0.15-0.81, p = 0.015).",
              "Sentence": "CYP2B6 983TC/CC is associated with decreased CNS-related adverse events efavirenz treated individuals.",
              "Alleles": "TC/CC",
              "Metabolizer types": "intermediate metabolizer",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "PD/PK terms": "CNS-related adverse events",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "CYP2B6 983TT",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "Lower risk of CNS-related adverse events was associated with CYP2B6 983TC/CC (OR 0.35, 95 % CI 0.15-0.81, p = 0.015) and higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively).",
                "A decreased risk of CNS adverse events (Stocrin\u00ae product information) was associated with CYP2B6 983TC or CC carriers (OR 0.30, 95 % CI 0.12-0.75, p = 0.010) but an increased risk in patients with CYP2B6 15582CT or TT and ABCB1 3435TT carriers was observed (OR 1.59, 95 % CI 1.11-2.27, p = 0.011; and OR 2.14, 95 % CI 1.25-3.67, p = 0.006, respectively)."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "983TC/CC",
            "gene": "CYP2B6",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "983TC/CC",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Lower risk of CNS-related adverse events was associated with CYP2B6 983TC/CC (OR 0.35, 95 % CI 0.15-0.81, p = 0.015).",
              "Sentence": "CYP2B6 983TC/CC is associated with decreased CNS-related adverse events efavirenz treated individuals.",
              "Alleles": "TC/CC",
              "Metabolizer types": "intermediate metabolizer",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "PD/PK terms": "CNS-related adverse events",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "CYP2B6 983TT",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "Lower risk of CNS-related adverse events was associated with CYP2B6 983TC/CC (OR 0.35, 95 % CI 0.15-0.81, p = 0.015) and higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively).",
                "A decreased risk of CNS adverse events (Stocrin\u00ae product information) was associated with CYP2B6 983TC or CC carriers (OR 0.30, 95 % CI 0.12-0.75, p = 0.010) but an increased risk in patients with CYP2B6 15582CT or TT and ABCB1 3435TT carriers was observed (OR 1.59, 95 % CI 1.11-2.27, p = 0.011; and OR 2.14, 95 % CI 1.25-3.67, p = 0.006, respectively)."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "CYP2B6",
            "gene": "CYP2B6",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "CYP2B6",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Higher risk of CNS-related adverse events was associated with CYP2B6 15582CT/TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040).",
              "Sentence": "CYP2B6 15582CT/TT is associated with increased CNS-related adverse events efavirenz treated individuals.",
              "Alleles": "CT/TT",
              "Metabolizer types": "poor metabolizer",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "CNS-related adverse events",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "CYP2B6 15582CC",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively)",
                "CNS adverse events were similar between doses (42 % EFV400 vs. 46 % EFV600, p = 0.287)",
                "A higher rate of EFV-related adverse events and discontinuations due to these events for EFV600 were not driven by polymorphisms assessed."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "15582CT/TT",
            "gene": "CYP2B6",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "15582CT/TT",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Higher risk of CNS-related adverse events was associated with CYP2B6 15582CT/TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040).",
              "Sentence": "CYP2B6 15582CT/TT is associated with increased CNS-related adverse events efavirenz treated individuals.",
              "Alleles": "CT/TT",
              "Metabolizer types": "poor metabolizer",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "CNS-related adverse events",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "CYP2B6 15582CC",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively)",
                "CNS adverse events were similar between doses (42 % EFV400 vs. 46 % EFV600, p = 0.287)",
                "A higher rate of EFV-related adverse events and discontinuations due to these events for EFV600 were not driven by polymorphisms assessed."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "ABCB1",
            "gene": "ABCB1",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "ABCB1",
              "Gene": "ABCB1",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Higher risk of CNS-related adverse events was associated with ABCB1 3435TT (OR 2.31, 95 % CI 1.33-4.02, p = 0.003).",
              "Sentence": "ABCB1 3435TT is associated with increased CNS-related adverse events efavirenz treated individuals.",
              "Alleles": "TT",
              "Metabolizer types": "",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "CNS-related adverse events",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "ABCB1 3435CC",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "...higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively).",
                "CNS adverse events were similar between doses (42 % EFV400 vs. 46 % EFV600, p = 0.287).",
                "Despite concerns regarding lower plasma concentrations obtained with efavirenz 400 mg (EFV400) compared with 600 mg (EFV600) in ENCORE1, virological efficacy was not compromised..."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "3435TT",
            "gene": "ABCB1",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "3435TT",
              "Gene": "ABCB1",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Higher risk of CNS-related adverse events was associated with ABCB1 3435TT (OR 2.31, 95 % CI 1.33-4.02, p = 0.003).",
              "Sentence": "ABCB1 3435TT is associated with increased CNS-related adverse events efavirenz treated individuals.",
              "Alleles": "TT",
              "Metabolizer types": "",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "CNS-related adverse events",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "ABCB1 3435CC",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "...higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively).",
                "CNS adverse events were similar between doses (42 % EFV400 vs. 46 % EFV600, p = 0.287).",
                "Despite concerns regarding lower plasma concentrations obtained with efavirenz 400 mg (EFV400) compared with 600 mg (EFV600) in ENCORE1, virological efficacy was not compromised..."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "CYP2B6",
            "gene": "CYP2B6",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "CYP2B6",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "dosage",
              "Significance": "yes",
              "Notes": "Possession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively).",
              "Sentence": "CYP2B6 516GT/TT is associated with increased risk of discontinuation of efavirenz in HIV-infected individuals.",
              "Alleles": "GT/TT",
              "Metabolizer types": "extensive metabolizer",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "discontinuation",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "CYP2B6 516GG",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "Possession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively).",
                "Following adjustment for age, sex and dose, and stratifying by country, CYP2B6 516GT, TT and CYP2A6*9B heterozygote or homozygous variant (CA or AA) patients had an 80, 166 and 100 % increased risk of overall discontinuation, respectively."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "516GT/TT",
            "gene": "CYP2B6",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "516GT/TT",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "dosage",
              "Significance": "yes",
              "Notes": "Possession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively).",
              "Sentence": "CYP2B6 516GT/TT is associated with increased risk of discontinuation of efavirenz in HIV-infected individuals.",
              "Alleles": "GT/TT",
              "Metabolizer types": "extensive metabolizer",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "discontinuation",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "CYP2B6 516GG",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "Possession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively).",
                "Following adjustment for age, sex and dose, and stratifying by country, CYP2B6 516GT, TT and CYP2A6*9B heterozygote or homozygous variant (CA or AA) patients had an 80, 166 and 100 % increased risk of overall discontinuation, respectively."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "NR1I2",
            "gene": "NR1I2",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "NR1I2",
              "Gene": "NR1I2",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "dosage",
              "Significance": "yes",
              "Notes": "NR1I2 63396TT carriers were at decreased risk of discontinuation by 22 %.",
              "Sentence": "NR1I2 63396TT is associated with decreased risk of discontinuation of efavirenz in HIV-infected individuals.",
              "Alleles": "TT",
              "Metabolizer types": "",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "PD/PK terms": "discontinuation",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "NR1I2 63396CC",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "Posession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively), whereas NR1I2 63396TT carriers were at decreased risk (22 %).",
                "Following adjustment for age, sex and dose, and stratifying by country, CYP2B6 516GT, TT and CYP2A6*9B heterozygote or homozygous variant (CA or AA) patients had an 80, 166 and 100 % increased risk of overall discontinuation, respectively, whereas NR1I2 63396TT carriers had a 22 % reduced risk."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "63396TT",
            "gene": "NR1I2",
            "drug": "efavirenz",
            "annotation": {
              "Variant/Haplotypes": "63396TT",
              "Gene": "NR1I2",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "dosage",
              "Significance": "yes",
              "Notes": "NR1I2 63396TT carriers were at decreased risk of discontinuation by 22 %.",
              "Sentence": "NR1I2 63396TT is associated with decreased risk of discontinuation of efavirenz in HIV-infected individuals.",
              "Alleles": "TT",
              "Metabolizer types": "",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "PD/PK terms": "discontinuation",
              "Multiple drugs And/or": "",
              "Population types": "",
              "Population Phenotypes or diseases": "",
              "Comparison Allele(s) or Genotype(s)": "NR1I2 63396CC",
              "Comparison Metabolizer types": "",
              "Specialty Population": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "Posession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively), whereas NR1I2 63396TT carriers were at decreased risk (22 %).",
                "Following adjustment for age, sex and dose, and stratifying by country, CYP2B6 516GT, TT and CYP2A6*9B heterozygote or homozygous variant (CA or AA) patients had an 80, 166 and 100 % increased risk of overall discontinuation, respectively, whereas NR1I2 63396TT carriers had a 22 % reduced risk."
              ],
              "_expanded_from_multi_variant": true
            }
          }
        ]
      }
    },
    "phenotype_annotations": {
      "score": 0.7130261125663916,
      "total_samples": 8,
      "ground_truth_annotations": {
        "count": 8,
        "matched_count": 7,
        "unmatched_count": 1,
        "items": [
          {
            "matched": true,
            "overall_match_score": 0.7764724314212799,
            "annotation": {
              "Variant/Haplotypes": "CYP2B6*1",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Efficacy",
              "Alleles": "*9",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Phenotype": "Efficacy:Discontinuation",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "*1/*1"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*1",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "dosage",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Alleles": {
                "ground_truth": "*9",
                "prediction": "GT/TT",
                "score": 0.8314046263694763,
                "match_status": "partial_match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Discontinuation",
                "prediction": "overall discontinuation",
                "score": 0.9333196878433228,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.7700040280818939,
            "annotation": {
              "Variant/Haplotypes": "CYP2B6*1",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Efficacy",
              "Alleles": "*9",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Phenotype": "Efficacy:Discontinuation",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "*1/*1"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*1",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Alleles": {
                "ground_truth": "*9",
                "prediction": "CT/TT",
                "score": 0.8348969221115112,
                "match_status": "partial_match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Discontinuation",
                "prediction": "CNS-related adverse events",
                "score": 0.865143358707428,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.7888509273529053,
            "annotation": {
              "Variant/Haplotypes": "rs4803419",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Toxicity",
              "Alleles": "CT + TT",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Phenotype": "Side Effect:Central Nervous System Disorder",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "CC"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4803419",
                "prediction": "15582CT/TT",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity",
                "score": 1.0,
                "match_status": "match"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "CT/TT",
                "score": 0.9514200687408447,
                "match_status": "match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events",
                "score": 0.937089204788208,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.7876518368721008,
            "annotation": {
              "Variant/Haplotypes": "rs28399499",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Toxicity",
              "Alleles": "CC + CT",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "Phenotype": "Side Effect:Central Nervous System Disorder",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "TT"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "rs28399499",
                "prediction": "CYP2B6",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity",
                "score": 1.0,
                "match_status": "match"
              },
              "Alleles": {
                "ground_truth": "CC + CT",
                "prediction": "TC/CC",
                "score": 0.9394291639328003,
                "match_status": "partial_match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events",
                "score": 0.937089204788208,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.7876518368721008,
            "annotation": {
              "Variant/Haplotypes": "rs28399499",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Toxicity",
              "Alleles": "CC + CT",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "Phenotype": "Side Effect:Central Nervous System Disorder",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "TT"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "rs28399499",
                "prediction": "983TC/CC",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity",
                "score": 1.0,
                "match_status": "match"
              },
              "Alleles": {
                "ground_truth": "CC + CT",
                "prediction": "TC/CC",
                "score": 0.9394291639328003,
                "match_status": "partial_match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events",
                "score": 0.937089204788208,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.782331907749176,
            "annotation": {
              "Variant/Haplotypes": "rs1045642",
              "Gene": "ABCB1",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Toxicity",
              "Alleles": "AA",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Phenotype": "Side Effect:Central Nervous System Disorder",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "GG"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "rs1045642",
                "prediction": "ABCB1",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "ABCB1",
                "prediction": "ABCB1",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity",
                "score": 1.0,
                "match_status": "match"
              },
              "Alleles": {
                "ground_truth": "AA",
                "prediction": "TT",
                "score": 0.8862298727035522,
                "match_status": "partial_match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events",
                "score": 0.937089204788208,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "GG",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.6877328336238862,
            "annotation": {
              "Variant/Haplotypes": "rs3745274",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "Phenotype Category": "Efficacy",
              "Alleles": "GT + TT",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Phenotype": "Efficacy:Discontinuation",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "GG"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "rs3745274",
                "prediction": "516GT/TT",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "dosage",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Alleles": {
                "ground_truth": "GT + TT",
                "prediction": "GT/TT",
                "score": 0.9440086483955383,
                "match_status": "partial_match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased",
                "score": 1.0,
                "match_status": "match"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Discontinuation",
                "prediction": "overall discontinuation",
                "score": 0.9333196878433228,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "GG",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": false,
            "annotation": {
              "Variant Annotation ID": 1448993794,
              "Variant/Haplotypes": "rs2472677",
              "Gene": "NR1I2",
              "Drug(s)": "efavirenz",
              "PMID": 26715213,
              "Phenotype Category": "Efficacy",
              "Significance": "yes",
              "Notes": null,
              "Sentence": "Genotype TT is associated with decreased likelihood of discontinuation when treated with efavirenz in people with HIV Infections as compared to genotypes CC + CT.",
              "Alleles": "TT",
              "Specialty Population": null,
              "Metabolizer types": null,
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "Side effect/efficacy/other": "likelihood of",
              "Phenotype": "Efficacy:Discontinuation",
              "Multiple phenotypes And/or": "and",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Multiple drugs And/or": null,
              "Population types": "in people with",
              "Population Phenotypes or diseases": "Disease:HIV infectious disease",
              "Multiple phenotypes or diseases And/or": null,
              "Comparison Allele(s) or Genotype(s)": "CC + CT",
              "Comparison Metabolizer types": null,
              "PMID_norm": "26715213",
              "Variant Annotation ID_norm": "1448993794"
            }
          }
        ]
      },
      "extra_predictions": {
        "count": 2,
        "items": [
          {
            "variant": "3435TT",
            "gene": "ABCB1",
            "drug": "efavirenz",
            "annotation": {
              "Variant Annotation ID": 3,
              "Variant/Haplotypes": "3435TT",
              "Gene": "ABCB1",
              "Drug(s)": "efavirenz",
              "PMID": 26715213,
              "Phenotype Category": "toxicity",
              "Significance": "yes",
              "Notes": "Higher risk of CNS-related adverse events found in ABCB1 3435TT carriers.",
              "Sentence": "ABCB1 3435TT is associated with increased risk of CNS-related adverse events when treated with efavirenz in treatment-nai\u0308ve HIV-infected patients.",
              "Alleles": "TT",
              "Specialty Population": null,
              "Metabolizer types": "not stated",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Side effect/efficacy/other": "risk of",
              "Phenotype": "CNS-related adverse events",
              "Multiple phenotypes And/or": null,
              "When treated with/exposed to/when assayed with": "when treated with",
              "Multiple drugs And/or": null,
              "Population types": null,
              "Population Phenotypes or diseases": null,
              "Multiple phenotypes or diseases And/or": null,
              "Comparison Allele(s) or Genotype(s)": null,
              "Comparison Metabolizer types": null,
              "PMID_norm": null,
              "Variant Annotation ID_norm": null,
              "Citations": [
                "Lower risk of CNS-related adverse events was associated with CYP2B6 983TC/CC (OR 0.35, 95 % CI 0.15-0.81, p = 0.015) and higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02-2.09, p = 0.040; OR 2.31, 95 % CI 1.33-4.02, p = 0.003, respectively).",
                "Possession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively), whereas NR1I2 63396TT carriers were at decreased risk (22 %).",
                "...CNS adverse events were not driven by EFV dose or concentrations; however, CYP2B6 15582CT/TT and ABCB1 3435TT carriers were at higher risk (46 and 131 %, respectively) of CNS-related adverse events compared with 35 % lower risk in CYP2B6 983TC/CC patients."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "Dose",
            "gene": "N/A",
            "drug": "efavirenz",
            "annotation": {
              "Variant Annotation ID": 4,
              "Variant/Haplotypes": "Dose",
              "Gene": "N/A",
              "Drug(s)": "efavirenz",
              "PMID": 26715213,
              "Phenotype Category": "dosage",
              "Significance": "yes",
              "Notes": "Discontinuation due to adverse events associated with dosage.",
              "Sentence": "Higher dose (600 mg) is associated with increased discontinuation due to adverse events when treated with efavirenz in treatment-nai\u0308ve HIV-infected patients.",
              "Alleles": null,
              "Specialty Population": null,
              "Metabolizer types": "not stated",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "Side effect/efficacy/other": "likelihood of",
              "Phenotype": "discontinuation due to adverse events",
              "Multiple phenotypes And/or": null,
              "When treated with/exposed to/when assayed with": "when treated with",
              "Multiple drugs And/or": null,
              "Population types": null,
              "Population Phenotypes or diseases": null,
              "Multiple phenotypes or diseases And/or": null,
              "Comparison Allele(s) or Genotype(s)": null,
              "Comparison Metabolizer types": null,
              "PMID_norm": null,
              "Variant Annotation ID_norm": null,
              "Citations": [
                "Discontinuation due to adverse events (clinician decision) was independently associated with dose (OR 2.54, 95 % CI 1.19-5.43, p = 0.016).",
                "A higher rate of EFV-related adverse events and discontinuations due to these events for EFV600 were not driven by polymorphisms assessed.",
                "EFV-related adverse events and discontinuations due to these events were increased with dose."
              ]
            }
          }
        ]
      }
    },
    "functional_analysis": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 0,
        "matched_count": 0,
        "unmatched_count": 0,
        "items": []
      },
      "extra_predictions": {
        "count": 0,
        "items": []
      }
    },
    "study_parameters": {
      "score": 0.4542857142857143,
      "total_samples": 7,
      "ground_truth_annotations": {
        "count": 7,
        "matched_count": 5,
        "unmatched_count": 2,
        "items": [
          {
            "matched": true,
            "overall_match_score": 0.6411764705882353,
            "annotation": {
              "Study Parameters ID": 1448993822,
              "Variant Annotation ID": 1448993820,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 606.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.011",
              "Ratio Stat Type": "OR",
              "Ratio Stat": 1.59,
              "Confidence Interval Start": 1.11,
              "Confidence Interval Stop": 2.27,
              "Biogeographical Groups": "Multiple groups"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1448993822,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993820,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 606.0,
                "prediction": 606,
                "score": 1.0,
                "match_status": "match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "CYP2B6 15582CT/TT and ABCB1 3435TT carriers experiencing CNS-related adverse events",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.011",
                "prediction": "= 0.040",
                "score": 0.5,
                "match_status": "partial_match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat": {
                "ground_truth": 1.59,
                "prediction": 1.46,
                "score": 0.8,
                "match_status": "partial_match"
              },
              "Confidence Interval Start": {
                "ground_truth": 1.11,
                "prediction": 1.02,
                "score": 0.8,
                "match_status": "partial_match"
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.27,
                "prediction": 2.09,
                "score": 0.8,
                "match_status": "partial_match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups",
                "score": 1.0,
                "match_status": "match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.5764705882352942,
            "annotation": {
              "Study Parameters ID": 1448993785,
              "Variant Annotation ID": 1448993783,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 569.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.016",
              "Ratio Stat Type": "OR",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Multiple groups"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1448993785,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993783,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 569.0,
                "prediction": 606,
                "score": 0.8,
                "match_status": "partial_match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "C12 between 0.47 and 0.76 mg/L achieving pVL <200 copies/mL at 96 weeks",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.016",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups",
                "score": 1.0,
                "match_status": "match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.5529411764705883,
            "annotation": {
              "Study Parameters ID": 1448993833,
              "Variant Annotation ID": 1448993831,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 606.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.006",
              "Ratio Stat Type": "OR",
              "Ratio Stat": 2.14,
              "Confidence Interval Start": 1.25,
              "Confidence Interval Stop": 3.67,
              "Biogeographical Groups": "Multiple groups"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1448993833,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993831,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 606.0,
                "prediction": 606,
                "score": 1.0,
                "match_status": "match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Discontinuation due to adverse events (clinician decision)",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.006",
                "prediction": "= 0.016",
                "score": 0.5,
                "match_status": "partial_match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat": {
                "ground_truth": 2.14,
                "prediction": 2.54,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Confidence Interval Start": {
                "ground_truth": 1.25,
                "prediction": 1.19,
                "score": 0.9,
                "match_status": "partial_match"
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.67,
                "prediction": 5.43,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups",
                "score": 1.0,
                "match_status": "match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.5470588235294118,
            "annotation": {
              "Study Parameters ID": 1448993812,
              "Variant Annotation ID": 1448993810,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 606.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.01",
              "Ratio Stat Type": "OR",
              "Ratio Stat": 0.3,
              "Confidence Interval Start": 0.12,
              "Confidence Interval Stop": 0.75,
              "Biogeographical Groups": "Multiple groups"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1448993812,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993810,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 606.0,
                "prediction": 606,
                "score": 1.0,
                "match_status": "match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "CYP2B6 983TC/CC carriers experiencing CNS-related adverse events",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "= 0.015",
                "score": 0.5,
                "match_status": "partial_match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat": {
                "ground_truth": 0.3,
                "prediction": 0.35,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Confidence Interval Start": {
                "ground_truth": 0.12,
                "prediction": 0.15,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Confidence Interval Stop": {
                "ground_truth": 0.75,
                "prediction": 0.81,
                "score": 0.8,
                "match_status": "partial_match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups",
                "score": 1.0,
                "match_status": "match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.4882352941176471,
            "annotation": {
              "Study Parameters ID": 1448993769,
              "Variant Annotation ID": 1448993767,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 573.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.01",
              "Ratio Stat Type": "OR",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Multiple groups"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1448993769,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993767,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 573.0,
                "prediction": 606,
                "score": 0.8,
                "match_status": "partial_match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Treatment-nai\u0308ve HIV-infected adults, 32% female, 37% African, 33% Asian",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "= 0.204",
                "score": 0.5,
                "match_status": "partial_match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 5.25,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.41,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 67.9,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups",
                "score": 1.0,
                "match_status": "match"
              }
            }
          },
          {
            "matched": false,
            "annotation": {
              "Study Parameters ID": 1448993796,
              "Variant Annotation ID": 1448993794,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 570.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.008",
              "Ratio Stat Type": "OR",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Multiple groups",
              "Variant Annotation ID_norm": "1448993794"
            }
          },
          {
            "matched": false,
            "annotation": {
              "Study Parameters ID": 1448993766,
              "Variant Annotation ID": 1448993759,
              "Study Type": "cohort, clinical trial",
              "Study Cases": 546.0,
              "Study Controls": null,
              "Characteristics": null,
              "Characteristics Type": "Unknown",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.42",
              "Ratio Stat Type": "OR",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Multiple groups",
              "Variant Annotation ID_norm": "1448993759"
            }
          }
        ]
      },
      "extra_predictions": {
        "count": 0,
        "items": []
      }
    }
  }
}